384 filings
8-K
ACORQ
Acorda Therapeutics Inc
24 May 24
Regulation FD Disclosure
8:24am
8-K
ACORQ
Acorda Therapeutics Inc
25 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00pm
8-K
ACORQ
Acorda Therapeutics Inc
17 Apr 24
Acorda Therapeutics Announces Delisting from Nasdaq
9:10am
8-K
ACORQ
Acorda Therapeutics Inc
1 Apr 24
Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
8:12pm
8-K
ACORQ
Acorda Therapeutics Inc
13 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
pdo2twz g6gjaua37
11 Jan 24
Termination of a Material Definitive Agreement
8:33am
8-K
qz5ktabd7kze8cdb2pl3
1 Dec 23
Other Events
4:30pm
8-K
w3ay9j
13 Nov 23
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
4:16pm
8-K
ufo1tkn t6a9
8 Aug 23
Acorda Therapeutics Reports Second Quarter 2023 Financial Results
4:12pm
8-K
vmbba9ao8qs 5w9t9yk3
27 Jun 23
Departure of Directors or Certain Officers
4:35pm
8-K
6ebqz5o 216pjppt79xn
26 Jun 23
Other Events
4:30pm
8-K
rmtye13oa5qn7a fgpz
2 Jun 23
Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split
4:28pm
8-K
ud4bv4ypwnrla40j
1 Jun 23
Other Events
5:17pm
8-K
36c3laqo7xybz07v xd
31 May 23
Other Events
5:07pm
8-K
sd4ffkoc3fa
11 May 23
Acorda Therapeutics Reports First Quarter 2023 Financial Results
4:15pm
8-K
3pecrjk4ax39d
10 May 23
Other Events
8:00am
8-K
iou0jwk5va9ywxbhb
8 May 23
Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China
5:16pm
8-K
w3ibtq4d
16 Mar 23
Other Events
8:16pm
8-K
bi46yhn7
9 Mar 23
Acorda Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
7:38am
8-K
lrw44hq09n6
15 Feb 23
Acorda Therapeutics Receives Nasdaq Extension to Meet Minimum Bid Price Requirement
11:18am